An observational study in Peri-implant Mucositis and Peri-Implantitis, sponsored by Universitat Internacional de Catalunya. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-17.
Sponsored by Universitat Internacional de Catalunya · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Peri-Implantitis by Universitat Internacional de Catalunya — 6 open to participants now, 6 under way, none of them phase 3. Peri-Implantitis · Universitat Internacional de Catalunya.
Among the 15 studies in Peri-Implantitis by Universitat Internacional de Catalunya, this one is one of 2 that started in 2024, is one of 6 observational ones, and was the 13th registered.
324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.
Browse Peri-Implantitis studies →6 of the 15 studies in Peri-Implantitis by Universitat Internacional de Catalunya are open now, in 1 country. Recruiting first, the newest first:
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+ · Healthy volunteers
Universitat Internacional de Catalunya · Sites in Spain
Ages 18–80
Universitat Internacional de Catalunya · Sites in Spain
Ages 21–80 · Healthy volunteers
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+
Universitat Internacional de Catalunya
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 180 is above the median of 84 across 122 observational studies indexed under Peri-Implantitis.
Median enrollment 36 across the 9 interventional studies, 143 across the 6 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Universitat Internacional de Catalunya is the lead sponsor of 151 studies on the registry; 46 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Peri-Implantitis by Universitat Internacional de Catalunya, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of this study is to analyse contiguous dental implants and its peri-implant status depending on different inter-implant distances.
The present research project has been designed as a multicentric cross-sectional study. The STROBE guidelines have been followed in the design of this observational study.
Ethical issues The study will be performed after the approval of the Ethics Committee of the Universitat Internacional de Catalunya (UIC) and Faculdade de Medicina Dentária da Universidade de Lisboa (FMDUL) and will be intended to be registered in clinicaltrials.gov. Also, this research will be conducted according to the principles outlined in the Declaration of Helsinki (revised, amended, and clarified in 2013). In addition, all study participants will provide written informed consent before participating in the study.
Study population Subjects will be selected from an electronic database collected at the CUO (UIC) / CU (FMDUL) and composed of patients treated with at least two contiguous dental implants before 2021. This investigation will use a stratified random sampling based on year of implant placement to select a representative sample of subjects with implant-supported restorations conducted during the period 2001-2020 at the CUO and CU. Then, two examiners (I.T. / F.F.) will contact patients by telephone once every 2 days (with a maximum of 3 attempts) for an evaluation by the same investigators (I.T / F.F).
Criteria for subject selection will be as follows:
Moreover, the exclusion criteria will be the following:
Subjects will be selected from an electronic database collected at the CUO (UIC) / CU (FMDUL) and composed of patients treated with at least two contiguous dental implants before 2021. This investigation will use a stratified random sampling based on year of implant placement to select a representative sample of subjects with implant-supported restorations conducted during the period 2001-2020 at the CUO and CU. Then, two examiners (I.T. / F.F.) will contact patients by telephone once every 2 days (with a maximum of 3 attempts) for an evaluation by the same investigators (I.T / F.F).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Presence of an inter-implant distance ≤ 3mm
Diagnostic Test: Two contiguous dental implants placed with less ≤ 3mm from each other.
Presence of an inter-implant distance ≥ 3mm
Diagnostic Test: Two contiguous dental implants placed with > 3mm from each other.
Implant Placement of 2 contiguous dental implants with less ≤ 3mm from each other.
Implant Placement of 2 contiguous dental implants with \> 3mm from each other.
Prevalence of peri-implant diseases.
Prevalence of peri-implant mucositis and peri-implantitis.
Time frame: At least 36 months of function - at the moment of the evaluation
FMPI
Full Mouth Plaque Index
Time frame: At least 36 months of function - at the moment of the evaluation
FMBI
Full Mouth Bleeding Index
Time frame: At least 36 months of function - at the moment of the evaluation
mPI
modified Plaque Index
Time frame: At least 36 months of function - at the moment of the evaluation
mBI
modified Bleeding Index
Time frame: At least 36 months of function - at the moment of the evaluation
SoP
Suppuration on Probing
Time frame: At least 36 months of function - at the moment of the evaluation
PPD
Probing Pocket Depth
Time frame: At least 36 months of function - at the moment of the evaluation
MR
Mucosal Recession
Time frame: At least 36 months of function - at the moment of the evaluation
KM
Keratinized Mucosa
Time frame: At least 36 months of function - at the moment of the evaluation
Implant location
Implant location in the oral cavity
Time frame: At least 36 months of function - at the moment of the evaluation
Implant position
Implant position in the oral cavity
Time frame: At least 36 months of function - at the moment of the evaluation
Implant type
Implant type used
Time frame: At least 36 months of function - at the moment of the evaluation
Implant brand
Brand of the implant used
Time frame: At least 36 months of function - at the moment of the evaluation
Implant roughness
Type of implant roughness
Time frame: At least 36 months of function - at the moment of the evaluation
Implant diameter
Type of implant diameter
Time frame: At least 36 months of function - at the moment of the evaluation
Implant length
Length of the implant
Time frame: At least 36 months of function - at the moment of the evaluation
Apico-coronal position of the implant
Apico-coroal position
Time frame: At least 36 months of function - at the moment of the evaluation
Inter-implant distances (IID)
Inter-implant distance
Time frame: At least 36 months of function - at the moment of the evaluation
Implant placement protocol
Moment of the implant placement
Time frame: At least 36 months of function - at the moment of the evaluation
Bone grafting procedures (BGP) at implant placement
Bone grafting associated with the implant placement
Time frame: At least 36 months of function - at the moment of the evaluation
Implant-supported restorations
Screwed or Cemented
Time frame: At least 36 months of function - at the moment of the evaluation
Cleansability of the prosthesis
Cleansable, difficult or impossible to clean
Time frame: At least 36 months of function - at the moment of the evaluation
PDFs hosted by the registry, ClinicalTrials.gov.
Started Apr 2024 (actual). Primary completion is estimated for Dec 2024, 8 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitat Internacional de Catalunya →